Catecholamine receptors and cyclic AMP formation in the central nervous system: effects of tetrahydroisoquinoline derivatives.
D000317:Adrenergic alpha-Antagonists / Q000378:metabolism; D000526:Alprenolol / Q000031:analogs & derivatives / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D000242:Cyclic AMP / Q000096:biosynthesis*; D004146:Dioxanes / Q000378:metabolism; D006220:Haloperidol / Q000378:metabolism; D007546:Isoquinolines / Q000494:pharmacology*; D010647:Phenyl Ethers / Q000378:metabolism; D013765:Tetrahydropapaveroline / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D002395:Catecholamines; D004146:Dioxanes; D007546:Isoquinolines; D010647:Phenyl Ethers; D013765:Tetrahydropapaveroline; D000526:Alprenolol; D000242:Cyclic AMP; D006220:Haloperidol